Blood amyloid-β oligomerization associated with neurodegeneration of Alzheimer’s disease

Table 1 Demographics of the subjects

	Subject number (female to male)	MDS-OAβ	Age
Sex
Female	98	0.904 ± 0.130	63.1 ± 9.6
Male	64	0.901 ± 0.134	62.9 ± 8.8
Clinical state
HNC	92 (53:39)	0.852 ± 0.130	60.5 ± 7.5
SCD	17(10:7)	0.925 ± 0.111	66.1 ± 9.5
MCI	15(9:6)	0.964 ± 0.098**	70.0 ± 9.2**
AD	38(26:12)	0.993 ± 0.089***	65.1 ± 11.1*

HNC healthy normal control, SCD subjective cognitive decline, MCI mild cognitive impairment; AD Alzheimer’s disease dementia
*p value < 0.05, **p value < 0.01, ***p value < 0.001, a significance of the difference when compared with Healthy Normal Control by ANOVA using R package

ISSN: 1758-9193